They've got growth. Just from crap absolute levels vs their expenses.
How these clowns could let cash levels run so low for so long, or not sign the Innoventure deal or CellHeal deal, with some up front payments, done since July/Sep 2023 bemuses me. This Board should go if this company makes it through to partnerships. Not just the CEO, strategically appalling fiduciary management.
OSX Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)